Brepocitinib Phase 2/3 Trial for Lichen Planopilaris in Adults

This document is a clinical trial registration entry on ClinicalTrials.gov for a Phase 2/3 study of brepocitinib in adults with lichen planopilaris. The registration provides standard trial metadata including condition, interventions (brepocitinib and placebo), and phase classification. No changes to existing regulations are made.

Affected parties including pharmaceutical companies, clinical investigators, and healthcare providers may reference this registration for awareness of ongoing dermatological research. The document does not impose compliance deadlines, penalties, or required actions on regulated entities.